Arginase 2 is a Diagnostic and Prognostic Marker for Prostate Cancer and Is Associated with Metabolism.
These findings suggest that ARG2 has been tentatively identified as a new target for research into how PCa develops in metabolism and for the development of innovative targeted treatments.
Authors
- Chaojiang Chen
- Weide Zhong (ORCID: https://orcid.org/0000-0002-0430-2845)
- Funeng Jiang (ORCID: https://orcid.org/0000-0001-8995-975X)
- Minyao Jiang
- Zhuoyuan Lin (ORCID: https://orcid.org/0000-0002-1697-6740)
- Jianxin Li (ORCID: https://orcid.org/0000-0001-9863-6493)
- Xing Zhou (ORCID: https://orcid.org/0000-0002-6931-2518)
- Jiangang Pan
- Yu Zheng
- Yuxiang Liang
Publication Details
- Journal
- PubMed
- Published
- 2024-09-01
- Citations
- 1
- Primary Topic
- Metabolism and Genetic Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.38